| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.04 |